| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/01/1994 | EP0599077A2 Anti-metastatic vaccine |
| 06/01/1994 | EP0598905A1 STABILIZED IL-1$g(a) PHARMACEUTICAL PREPARATION |
| 06/01/1994 | EP0598840A1 Human calcium channel compositions and methods |
| 06/01/1994 | EP0598839A1 Purine-region dna binding protein |
| 06/01/1994 | EP0598832A1 Dna sequencing with a t7-type gene 6 exonuclease |
| 06/01/1994 | EP0598816A1 Osp a proteins of borrelia burgdorferi subgroups, encoding genes and vaccines |
| 06/01/1994 | EP0598813A1 Immunostimulation |
| 06/01/1994 | EP0598806A1 Synthetic storage proteins with defined structure containing programmable levels of essential amino acids for improvement of the nutritional value of plants |
| 06/01/1994 | EP0598792A1 Osteoclast growth regulatory factor |
| 06/01/1994 | EP0598768A1 Nucleotide sequences coding for ribosome inactivating proteins |
| 06/01/1994 | EP0598759A1 Recombinant infectious bovine rhinotracheitis virus |
| 06/01/1994 | EP0511202B1 A cell surface antigen associated with cellular apoptosis |
| 06/01/1994 | EP0483143B1 Membrane affinity apparatus and purification methods related thereto |
| 06/01/1994 | EP0439458B1 Characterization and detection of sequences associated with autoimmune diseases |
| 06/01/1994 | EP0250501B2 A process for the preparation of a heat resistant non-bitter water-soluble peptide product, the product produced by the process, and nutrients, refreshments and dietetics comprising the product |
| 06/01/1994 | EP0172865B2 Dna sequences, recombinant dna and processes for producing antigens of plasmodium falciparum |
| 06/01/1994 | DE4240119A1 Recovering fully active fibrinogen from blood - in single step, by hydrophobic interaction partitioning between matrix and soln., provides high yields |
| 06/01/1994 | DE4239817A1 New protein tyrosine kinase and related nucleic acid - vectors, transformed cells, etc., useful for diagnosis and treatment of tumours |
| 06/01/1994 | DE4239816A1 Inhibiting glutamate-induced synaptic stimulus transfer - with specific spider toxins, for treating CNS disorders and characterisation of receptor channel sub-types |
| 06/01/1994 | DE4228458A1 Multicistronische Expressionseinheiten und deren Verwendung Multicistronic expression units and their use |
| 06/01/1994 | CN1024809C Microorganism having low acetate forming capability and process for production of useful substrate using same |
| 05/31/1994 | US5317097 DNA oligomers and genetic engineering |
| 05/31/1994 | US5317096 Transformation vectors allowing expression of foreign polypeptide endotoxins from Bacillus thuringiensis in plants |
| 05/31/1994 | US5317094 Detectors |
| 05/31/1994 | US5317092 Protein purification method |
| 05/31/1994 | US5317090 Steroid/thyroid hormone receptor-related gene, which is inappropriately expressed in human hepatocellular carcinoma, and which is a retinoic acid receptor |
| 05/31/1994 | US5317089 Monoclonal antibodies against IFN-omega, processes for preparing them and their use in the purification and detection of IFN-omega |
| 05/31/1994 | US5317088 Binding |
| 05/31/1994 | US5317087 Interleukin 2-receptor protein precipitates, monoclonal antibodies |
| 05/31/1994 | US5317085 Polypeptides for genetic engineering |
| 05/31/1994 | US5317084 Process for large-scale production of antimicrobal peptide in high purity |
| 05/31/1994 | US5317011 Cloning and expression of a variant gene of platelet factor 4 and compositions thereof to modulate immune responses |
| 05/31/1994 | US5317010 Parathyroid hormone analogues substituted at AA 25, 26, 27, and use in osteoporosis treatment |
| 05/31/1994 | US5317009 Anti-HIV proteins GAP 31, DAP 30 and DAP 32 and therapeutic uses thereof |
| 05/31/1994 | US5316947 Synthetic isohirudins with improved stability |
| 05/31/1994 | US5316942 Slurrying insoluble collagen, adjustment of pH to dissolve, adding proteolytic enzymes and water |
| 05/31/1994 | US5316937 Conditioned medium useful for sustaining growth of colonic crypt cells |
| 05/31/1994 | US5316934 Prourokinase mutein fused with oligopeptides and fibrin for DNA segments |
| 05/31/1994 | US5316933 Recombinant natural killer cell activator |
| 05/31/1994 | US5316931 Genetic engineering |
| 05/31/1994 | US5316925 T-cell receptor specific for antigen polypeptides and related polynucleotides |
| 05/31/1994 | US5316923 Synthetic yeast leader peptides |
| 05/31/1994 | US5316922 Binding proteins, ligation polynucleotides and insertion gene coding |
| 05/31/1994 | US5316921 Which are resistant to proteolytic cleavage by enzymes capable of in vivo conversion of hgf into it's two chain form |
| 05/31/1994 | US5316920 Lymphocyte activation antigen HB15, a member of the immunoglobulin superfamily |
| 05/31/1994 | US5316919 Genetic engineering; vasodialtors, hypotensive and bronchodilator agents |
| 05/31/1994 | US5316910 Bioassay for influenza A and B nucleoprotein |
| 05/31/1994 | US5316775 Method of treating hepatitis B infection |
| 05/31/1994 | US5316764 Immunization of dogs to form antibodies |
| 05/31/1994 | US5316754 In vitro assay of mesangial cell-derived receptors for advanced glycosylation endproducts |
| 05/26/1994 | WO1994011738A1 Determination of peptide motifs on mhc molecules |
| 05/26/1994 | WO1994011737A1 Method for detection of a new marker associated with hepatitis delta virus infection |
| 05/26/1994 | WO1994011533A1 METHODS FOR DETERMINING THE PRESENCE OF FUNCTIONAL p53 IN MAMMALIAN CELLS |
| 05/26/1994 | WO1994011532A1 Methods of detecting a genetic predisposition for osteoarthritis |
| 05/26/1994 | WO1994011525A1 Improved recombinant production of proteins having factor viii:c activity |
| 05/26/1994 | WO1994011524A1 Targetable vector particles |
| 05/26/1994 | WO1994011521A1 Bovine heat shock promoter and uses thereof |
| 05/26/1994 | WO1994011514A1 Human endogenous retrovirus-k-envelope-gene encoded glycoprotein, and a monoclonal antibody for diagnostic and therapeutic purposes |
| 05/26/1994 | WO1994011513A1 Heat shock proteins and the treatment of tumours |
| 05/26/1994 | WO1994011512A2 Allergenic proteins and peptides from japanese cedar pollen |
| 05/26/1994 | WO1994011511A1 Biocidal chitin binding proteins |
| 05/26/1994 | WO1994011510A2 Modulators of hematopoietic progenitor cells |
| 05/26/1994 | WO1994011508A2 Polypeptides with specificity for neoplasias, kit, and diagnostic, vaccination, and therapeutic methods |
| 05/26/1994 | WO1994011506A1 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle |
| 05/26/1994 | WO1994011505A1 Pars planitis specific polypeptides |
| 05/26/1994 | WO1994011504A1 C-c ckr-1, c-c chemokine receptor |
| 05/26/1994 | WO1994011503A2 Chimeric factor viii |
| 05/26/1994 | WO1994011502A2 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use |
| 05/26/1994 | WO1994011501A1 cDNAs ENCODING HUMAN NMDA-22A RECEPTOR SUBUNIT AND ISOFORMS OF THE HUMAN NMDA-R1 RECEPTOR SUBUNIT, TRANSFECTED CELL LINE EXPRESSING THEM |
| 05/26/1994 | WO1994011500A1 Novel polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof |
| 05/26/1994 | WO1994011499A1 Flk-1 is a receptor for vascular endothelial growth factor |
| 05/26/1994 | WO1994011498A1 Glycoprotein ligand for p-selectin and methods of use thereof |
| 05/26/1994 | WO1994011497A1 Method of causing selective immunosuppression using hl-60-related lectins |
| 05/26/1994 | WO1994011405A1 Novel propoxyphene derivatives and protein and polypeptide propoxyphene derivative conjugates and labels |
| 05/26/1994 | WO1994011402A1 Mutant interleukin 6 with improved biological activity over wild interleukin 6 |
| 05/26/1994 | WO1994011401A1 Human homolog of the e-cadherin gene and methods based thereon |
| 05/26/1994 | WO1994011400A1 Peptides from human icam-2 and from human icam-1 and their analogs for use in therapy and diagnosis |
| 05/26/1994 | WO1994011399A1 Specifically crosslinked hemoglobin with free functionality |
| 05/26/1994 | WO1994011398A1 CYCLIC COMPOUNDS LINKED BY A HETEROCYCLIC RING USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa |
| 05/26/1994 | WO1994011397A1 Ghrh agonists |
| 05/26/1994 | WO1994011396A1 Ghrh agonists |
| 05/26/1994 | WO1994011395A1 Peptide inhibitors of fibronectin and related collagen-binding proteins |
| 05/26/1994 | WO1994011394A2 Peptides with organo-protective activity, process for their preparation and their use in the therapy |
| 05/26/1994 | WO1994011392A1 Peptide inhibitors of tyrosine kinases and therapeutic uses thereof |
| 05/26/1994 | WO1994011389A1 Biological mediators of immune functions |
| 05/26/1994 | WO1994011384A1 Novel cytokine designated elk ligand |
| 05/26/1994 | WO1994011348A1 Detection of hypoxia |
| 05/26/1994 | WO1994011029A1 Human tissue factor related dna segments, polypeptides and antibodies |
| 05/26/1994 | WO1994011028A1 Compounds having reduced immunogenicity and a method of reducing the immunogenicity of compounds |
| 05/26/1994 | WO1994011025A1 Pathogenic porcine respiratory coronavirus |
| 05/26/1994 | WO1994011024A1 Composition protective against p. multocida pasteurellosis infection |
| 05/26/1994 | WO1994011023A1 Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
| 05/26/1994 | WO1994011020A1 Eck receptor ligands |
| 05/26/1994 | WO1994011019A1 Materials and methods for immunocontraception |
| 05/26/1994 | WO1994011018A1 Opioid peptides |
| 05/26/1994 | WO1994011016A1 Specific immune system modulation |
| 05/26/1994 | WO1994011015A1 Lipophilic peptide-based carriers for targeted drug delivery using rational drug-binding design |
| 05/26/1994 | WO1994011014A1 Compounds that inhibit t cell proliferation and methods using the same |
| 05/26/1994 | WO1994011013A1 Chimeric blood coagulation proteins |
| 05/26/1994 | WO1994010831A1 Induction of dwarfing and early flowering using group 3 lea proteins |